Zai Lab Ltd - 20-F filing on 2018-04-30

Loss Per Share (Tables)

12 Months Ended

Dec. 31, 2017

Summary of Basic and Diluted Net Loss Per Share

Basic and diluted net loss per share for each of the years presented are calculated as follow:

	For the year ended December 31,
	2015			2016			2017
Numerator:
Net loss attributable to ordinary shareholders		(18,021,737	)		(37,512,212	)		(50,384,176	)
Denominator:
Weighted average number of ordinary shares- basic and diluted		8,693,655			9,439,028			21,752,757
Net loss per share-basic and diluted		(2.07	)		(3.97	)		(2.32	)

Summary of Anti-Dilutive Shares Excluded from Calculation of Diluted Loss Per Share

As a result of the Group’s net loss for the three years ended December 31, 2015, 2016 and 2017, preferred shares, share options, non-vested restricted shares and warrants outstanding in the respective periods were excluded from the calculation of diluted loss per share as their inclusion would have been anti-dilutive.

	As of December 31,
	2015		2016		2017
Number of Series A1 Shares outstanding		8,466,665		8,466,665		—
Number of Series A2 Shares outstanding		8,442,221		8,442,221		—
Number of Series B1 Shares outstanding		—		5,562,335		—
Number of Series B2 Shares outstanding		—		3,973,096		—
Share options		4,309,232		7,228,141		6,548,377
Non-vested restricted shares		2,948,148		2,309,490		693,333
Warrants		461,808		461,808		—